42 studies found for:
" January 16, 2008":" February 15, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
|
||||
| 2 | Unknown † |
Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
|
||||
| 3 | Recruiting |
Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
|
||||
| 4 | Unknown † |
Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
|
||||
| 5 |
Terminated
Has Results |
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
|
||||
| 6 | Completed |
HIV, Abuse, and Psychiatric Disorders Among Youth
|
||||
| 7 | Completed |
Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
|
||||
| 8 | Completed |
A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
|
||||
| 9 | Completed |
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
|
||||
| 10 | Completed |
Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241 AM3)(COMPLETED)
|
||||
| 11 | Completed |
Naïve HIV POC Monotherapy Trial
|
||||
| 12 | Active, not recruiting |
Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
|
||||
| 13 | Completed |
Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
|
||||
| 14 |
Completed
Has Results |
PRO 140 by IV Administration in Adults With HIV-1 Infection
|
||||
| 15 | Completed |
Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
|
||||
| 16 | Completed |
HIV and Hepatitis Care Coordination in Methadone Treatment
|
||||
| 17 | Completed |
ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
|
||||
| 18 | Completed |
Clinical Trial of CNS-targeted HAART (CIT2)
|
||||
| 19 | Terminated |
Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
|
||||
| 20 | Active, not recruiting |
A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial
|
† Indicates status has not been verified in more than two years
